![](/img/cover-not-exists.png)
84: Quality of life measures relating to the skin toxicities of tyrosine kinase inhibitor (TKI) use in lung cancer – what is in current use in the literature?
Watts, G.J., Nelson, A., Lester, J.F., Noble, S.I.Volume:
87
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(15)50083-4
Date:
January, 2015
File:
PDF, 46 KB
english, 2015